Advertisement
Screener

BAXTER INTERNATIONAL INC. (BAX) Graph

BAX Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $2.96B; Cost of revenue $1.93B; Research and development $129.00M; Selling, general and administrative $735.00M.
  • 2026-03-31: Revenue $2.70B; Cost of revenue $1.81B; Research and development $139.00M; Selling, general and administrative $728.00M.
  • 2025-12-31: Revenue $2.97B*; Cost of revenue $2.40B*; Research and development $126.00M*; Selling, general and administrative $761.00M*.
  • 2025-09-30: Revenue $2.83B; Cost of revenue $1.89B; Research and development $118.00M; Selling, general and administrative $708.00M.

Consolidation item

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

BAX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Corporate Non Segment$83.00MRevenue$2.96BCost of revenue$1.93BGross profit$1.03BOperating income$217.00MOther income, net$5.00MResearch & development$129.00MSelling, general& administrative$735.00MPre-tax income$158.00MIncome tax$23.00MNet income$126.00M

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

BAX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Non Us$1.36BUS$1.60BRevenue$2.96BCost of revenue$1.93BGross profit$1.03BOperating income$217.00MOther income, net$5.00MResearch & development$129.00MSelling, general& administrative$735.00MPre-tax income$158.00MIncome tax$23.00MNet income$126.00M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2026-06-30$2.96B$1.93B$129.00M$735.00M$23.00M$126.00M
2026-03-31$2.70B$1.81B$139.00M$728.00M$11.00M-$15.00M
2025-12-31$2.97B*$2.40B*$126.00M*$761.00M*$279.00M*-$1.13B*
2025-09-30$2.83B$1.89B$118.00M$708.00M$172.00M-$46.00M
2025-06-30$2.81B$1.82B$134.00M$718.00M$11.00M$91.00M
2025-03-31$2.63B$1.76B$140.00M$703.00M-$67.00M$126.00M
2024-12-31$2.75B(m)(m)(m)(m)-$512.00M
2024-09-30$2.70B$1.67B$129.00M$754.00M$8.00M$140.00M
2024-06-30$2.69B$1.66B$130.00M$723.00M$22.00M-$314.00M
2024-03-31$2.49B$1.53B$120.00M$729.00M$40.00M$37.00M
2023-12-31$2.73B(m)(m)(m)(m)$245.00M
2023-09-30$2.60B$1.54B$133.00M$744.00M$27.00M$2.51B
2023-06-30$2.59B$2.60B$165.00M$964.00M$10.00M-$141.00M
2023-03-31$2.44B$2.24B$164.00M$995.00M$14.00M$44.00M
2022-12-31$3.75B(m)(m)(m)(m)$181.00M
2022-09-30$3.61B$2.56B$151.00M$941.00M-$54.00M-$2.94B
2022-06-30$3.59B$2.22B$148.00M$970.00M$34.00M$252.00M
2022-03-31$3.56B$2.36B$150.00M$1.05B$21.00M$71.00M
2021-09-30$3.23B$1.91B$129.00M$680.00M-$1.00M$450.00M
2021-06-30$3.10B$1.86B$139.00M$675.00M$91.00M$298.00M
2021-03-31$2.95B$1.80B$128.00M$627.00M$51.00M$298.00M
2020-12-31$3.18B(m)(m)(m)(m)$168.00M
2020-09-30$2.97B$1.78B$123.00M$601.00M$56.00M$356.00M
2020-06-30$2.72B$1.68B$117.00M$590.00M$42.00M$246.00M
2020-03-31$2.80B$1.64B$146.00M$628.00M$45.00M$332.00M
2019-12-31$3.04B(m)(m)(m)(m)-$23.00M
2019-09-30$2.85B$1.62B$144.00M$627.00M$106.00M$369.00M
2019-06-30$2.83B$1.68B$166.00M$641.00M$13.00M$313.00M
2019-03-31$2.64B$1.56B$129.00M$601.00M$44.00M$342.00M
2018-12-31$2.83B$1.65B$175.00M$627.00M$102.00M$305.00M
2018-09-30$2.76B$1.53B$166.00M$684.00M-$146.00M$518.00M
2018-06-30$2.81B$1.59B$172.00M$676.00M$63.00M$341.00M
2018-03-31$2.69B$1.57B$141.00M$633.00M$46.00M$382.00M
2017-12-31$2.77B(m)(m)(m)(m)-$71.00M
2017-09-30$2.71B$1.58B$150.00M$680.00M$42.00M$251.00M
2017-06-30$2.60B$1.47B$155.00M$630.00M$42.00M$265.00M
2017-03-31$2.48B$1.43B$127.00M$564.00M$55.00M$272.00M
2016-12-31$2.65B(m)(m)(m)(m)$243.00M
2016-09-30$2.56B$1.49B$159.00M$726.00M$1.00M$130.00M
2016-06-30$2.58B$1.61B$195.00M$709.00M$6.00M$1.21B
2016-03-31$2.38B$1.41B$136.00M$641.00M-$58.00M$3.38B
2015-12-31$2.60B(m)(m)(m)(m)$205.00M
2015-09-30$2.49B$1.45B$148.00M$794.00M-$35.00M$1.00M
2015-06-30$2.48B$1.45B$151.00M$783.00M$34.00M$332.00M
2015-03-31$2.40B$1.38B$143.00M$784.00M$14.00M$430.00M
2014-12-31$2.79B(m)(m)(m)(m)$953.00M
2014-09-30$2.71B$1.52B$149.00M$827.00M$27.00M$468.00M
2014-06-30$2.70B$2.19B$322.00M$988.00M$134.00M$520.00M
2014-03-31$2.52B$1.96B$309.00M$910.00M$146.00M$556.00M
2013-12-31$4.32B(m)(m)(m)(m)$326.00M
2013-09-30$3.71B$1.80B$277.00M$975.00M$136.00M$544.00M
2013-06-30$3.57B$1.73B$273.00M$838.00M$153.00M$590.00M
2013-03-31$3.36B$1.69B$246.00M$795.00M$141.00M$552.00M
2012-12-31$3.75B(m)(m)(m)(m)$494.00M
2012-09-30$3.48B$1.67B$290.00M$743.00M$183.00M$583.00M
2012-06-30$3.57B$1.70B$306.00M$789.00M$156.00M$661.00M
2012-03-31$3.39B$1.67B$269.00M$752.00M$144.00M$588.00M
2011-12-31$3.59B(m)(m)(m)(m)$463.00M
2011-09-30$3.48B$1.71B$239.00M$787.00M$149.00M$576.00M
2011-06-30$3.54B$1.70B$239.00M$765.00M$174.00M$615.00M
2011-03-31$3.28B$1.61B$214.00M$716.00M$154.00M$570.00M
2010-12-31$3.50B(m)(m)(m)(m)$423.00M
2010-09-30$3.22B$1.56B$207.00M$670.00M$117.00M$525.00M
2010-06-30$3.19B$1.56B$219.00M$721.00M$133.00M$535.00M
2010-03-31$2.93B$1.88B$227.00M$683.00M$172.00M-$63.00M
2009-12-31$3.47B(m)(m)(m)(m)$572.00M
2009-09-30$3.15B$1.51B$228.00M$672.00M$126.00M$530.00M
2009-06-30$3.12B$1.49B$231.00M$660.00M$135.00M$587.00M
2009-03-31$2.82B$1.34B$212.00M$611.00M$119.00M$516.00M
2008-09-30$3.15B$1.63B$230.00M$681.00M$86.00M$472.00M
2008-06-30$3.19B$1.56B$222.00M$703.00M$128.00M$544.00M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2026-06-30$5.66B$3.74B$268.00M$1.46B$34.00M$111.00M
2025-06-30$5.43B$3.58B$274.00M$1.42B-$56.00M$217.00M
2024-06-30$5.18B$3.19B$250.00M$1.45B$62.00M-$277.00M
2023-06-30$7.22B$4.83B$329.00M$1.96B$24.00M-$97.00M
2022-06-30$7.15B$4.52B$297.00M$2.02B$40.00M$323.00M
2021-06-30$6.04B$3.67B$267.00M$1.30B$142.00M$596.00M
2020-06-30$5.52B$3.32B$263.00M$1.22B$87.00M$578.00M
2019-06-30$5.47B$3.24B$295.00M$1.24B$57.00M$655.00M
2018-06-30$5.50B$3.16B$313.00M$1.31B$109.00M$723.00M
2017-06-30$5.08B$2.90B$282.00M$1.19B$97.00M$537.00M
2016-06-30$4.96B$3.02B$331.00M$1.35B-$52.00M$4.59B
2015-06-30$4.88B$2.84B$294.00M$1.57B$48.00M$762.00M
2014-06-30$8.00B$4.14B$631.00M$1.90B$280.00M$1.08B
2013-06-30$7.12B$3.42B$519.00M$1.63B$294.00M$1.14B
2012-06-30$6.96B$3.37B$575.00M$1.54B$300.00M$1.25B
2011-06-30$6.82B$3.31B$453.00M$1.48B$328.00M$1.19B
2010-06-30$6.12B$3.44B$446.00M$1.40B$305.00M$472.00M
2009-06-30$5.95B$2.82B$443.00M$1.27B$254.00M$1.10B
2008-06-30$6.07B$3.06B$412.00M$1.34B$233.00M$973.00M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2025-09-30$8.27B$5.47B$392.00M$2.13B$116.00M$171.00M
2024-09-30$7.88B$4.86B$379.00M$2.21B$70.00M-$137.00M
2023-09-30$7.63B$4.58B$391.00M$2.27B$59.00M$2.41B
2022-09-30$10.76B$7.08B$448.00M$2.96B-$14.00M-$2.61B
2021-09-30$9.27B$5.57B$396.00M$1.98B$141.00M$1.05B
2020-09-30$8.49B$5.10B$386.00M$1.82B$143.00M$934.00M
2019-09-30$8.32B$4.86B$439.00M$1.87B$163.00M$1.02B
2018-09-30$8.27B$4.69B$479.00M$1.99B-$37.00M$1.24B
2017-09-30$7.79B$4.48B$432.00M$1.87B$139.00M$788.00M
2016-09-30$7.52B$4.51B$490.00M$2.08B-$51.00M$4.72B
2015-09-30$7.37B$4.29B$442.00M$2.36B$13.00M$763.00M
2014-09-30$7.93B$4.56B$454.00M$2.46B$51.00M$1.54B
2013-09-30$10.64B$5.17B$769.00M$2.59B$419.00M$1.69B
2012-09-30$10.44B$5.04B$865.00M$2.28B$483.00M$1.83B
2011-09-30$10.30B$5.02B$692.00M$2.27B$477.00M$1.76B
2010-09-30$9.35B$5.00B$653.00M$2.07B$422.00M$997.00M
2009-09-30$9.09B$4.33B$671.00M$1.94B$380.00M$1.63B
2008-09-30$9.22B$4.69B$642.00M$2.02B$319.00M$1.45B

Revenue and expense 12 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2025-12-31$11.24B(m)$7.87B$518.00M$2.89B$395.00M-$957.00M
2024-12-31$10.64B(m)$6.65B$590.00M$2.97B$37.00M-$649.00M
2023-12-31$10.36B(m)$6.21B$518.00M$2.95B$61.00M$2.66B
2022-12-31$10.06B(m)$6.51B$450.00M$3.10B-$135.00M-$2.43B
2021-12-31$12.15B(m)$7.43B$531.00M$2.85B$83.00M$1.28B
2020-12-31$11.67B$11.67B$7.09B$521.00M$2.47B$182.00M$1.10B
2019-12-31$11.36B$11.36B$6.60B$595.00M$2.54B-$41.00M$1.00B
2018-12-31$11.10B$11.10B$6.34B$654.00M$2.62B$65.00M$1.55B
2017-12-31$10.58B$10.58B$6.11B$615.00M$2.63B$491.00M$602.00M
2016-12-31$10.16B(m)$6.05B$646.00M$2.73B-$12.00M$4.96B
2015-12-31$9.97B(m)$5.78B$587.00M$3.03B$35.00M$968.00M
2014-12-31$10.72B(m)$6.14B$610.00M$3.31B$33.00M$2.50B
2013-12-31$9.41B(m)$5.25B$582.00M$3.08B$60.00M$2.01B
2012-12-31$13.94B(m)$6.80B$1.08B$3.28B$555.00M$2.33B
2011-12-31$13.89B(m)$6.85B$946.00M$3.15B$553.00M$2.22B
2010-12-31$12.84B(m)$6.88B$915.00M$2.91B$463.00M$1.42B
2009-12-31$12.56B(m)$6.04B$917.00M$2.73B$519.00M$2.21B
2008-12-31$12.35B(m)$6.22B$868.00M$2.70B$437.00M$2.01B
2007-12-31$11.26B(m)$5.74B$760.00M$2.52B$407.00M$1.71B

Similar stocks

Stock NameCountryMarket CapPE Ratio
Penumbra Inc (PEN)United States$12.596B77.33
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
Solventum Corp (SOLV)United States$15.085B9.16
GLAUKOS Corp (GKOS)United States$9.135B-43.73
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44
HAEMONETICS CORP (HAE)United States$4.821B36.52
Heartflow, Inc. (HTFL)United States$4.225B